← Open Payments lookup

BRYNN KANNE: Open Payments

NPI 1437911005 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$251 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $251

Food & beverage: $251
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.4$84
Lilly USA, LLC3$44
Bayer Healthcare Pharmaceuticals Inc.2$28
ABBVIE INC.1$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$18
Janssen Pharmaceuticals, Inc1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Otsuka America Pharmaceutical, Inc.1$16

Products named: GEMTESA, MOUNJARO, Kerendia, QULIPTA, JARDIANCE, SPRAVATO, XIFAXAN, REXULTI.

Industry payments across NE — which companies pay providers there.